Cite
Faure C, Djerbi-Bouillié R, Domingot A, et al. Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases. Cancer Res. 2021;81(21):5464-5476doi: 10.1158/0008-5472.CAN-21-0162.
Faure, C., Djerbi-Bouillié, R., Domingot, A., Bouzinba-Segard, H., Taouji, S., Saidi, Y., Bernard, S., Carallis, F., Rothe-Walther, R., Lenormand, J. L., Chevet, E., & Bourdoulous, S. (2021). Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases. Cancer research, 81(21), 5464-5476. https://doi.org/10.1158/0008-5472.CAN-21-0162
Faure, Camille, et al. "Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases." Cancer research vol. 81,21 (2021): 5464-5476. doi: https://doi.org/10.1158/0008-5472.CAN-21-0162
Faure C, Djerbi-Bouillié R, Domingot A, Bouzinba-Segard H, Taouji S, Saidi Y, Bernard S, Carallis F, Rothe-Walther R, Lenormand JL, Chevet E, Bourdoulous S. Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases. Cancer Res. 2021 Nov 01;81(21):5464-5476. doi: 10.1158/0008-5472.CAN-21-0162. Epub 2021 Sep 07. PMID: 34493594.
Copy
Download .nbib